TP53 and urinary bladder cancer: By WES, we identified mutations in many known UBC driver genes, including KDM6A, TP53, and FGFR3. However, few of these driver mutations are enriched in recurrent bladder cancer or PD-L1 over-expressing cases (Figure S10).